Truist Financial and TD Cowen raised target prices and issued buy ratings for Astrana Health, Inc. on June 10, 2026.
4 reports, 2 independent
Updated Aug 17
Gone quiet
- Reports
- 4
- Developments
- 3
- Repetition
- 25%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial and TD Cowen raised target prices and issued buy ratings for Astrana Health, Inc. on June 10, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Multiple firms, including Needham and SNB, issued rating and target updates for Astrana Health.1 source
TD Cowen and Truist Financial raised price targets for Astrana Health.1 source
Truist Financial and TD Cowen upgraded their ratings for Astrana Health, Inc.1 source
Keep exploring
The entities involved
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
-
TD Cowen
American investment bank
Related events
- Truist Financial boosted price target and gave buy rating, and TD Cowen lifted target price and gave buy rating for Encompass Health.
- TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.
- TD Cowen increased its target price and issued a buy rating for Butterfly Network, with MarketBeat aggregating the data.
- TD Cowen raised price targets for GoodRx stock.
- BTIG, Jefferies, and TD Cowen raised price targets for J.Jill Inc.